On Thursday, the Centers for Disease Control and Prevention said that there have been a higher-than-expected number of cases of..
Moderna COVID-19 vaccine
RNA COVID-19 vaccine
The Moderna COVID‑19 vaccine, codenamed mRNA-1273, is a COVID-19 vaccine developed by Moderna, the United States National Institute of Allergy and Infectious Diseases (NIAID) and the Biomedical Advanced Research and Development Authority (BARDA). It is used in people aged 18 years and older to provide protection against infection by the SARS-CoV-2 virus, which causes COVID-19. It is designed to be administered as two 0.5 mL doses given by intramuscular injection at an interval of four weeks apart.
Moderna COVID-19 vaccine media coverage
On Tuesday, Moderna announced the results of their Phase 2 trial of the administration of their COVID-19 vaccine to children ages..
On May 5, Moderna reported results from its ongoing studies involving booster doses for its COVID-19 vaccine.